Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.
Vaeteewoottacharn K, Kariya R, Dana P, Fujikawa S, Matsuda K, Ohkuma K, Kudo E, Kraiklang R, Wongkham C, Wongkham S, Okada S.
Vaeteewoottacharn K, et al. Among authors: okada s.
Tumour Biol. 2016 Jul;37(7):9023-35. doi: 10.1007/s13277-016-4785-8. Epub 2016 Jan 13.
Tumour Biol. 2016.
PMID: 26762407